Polymorphisms of brain-derived neurotrophic factor associated with heroin dependence

Neuroscience Letters

Volumn 495, Issue 3, 2011, Pages 221-224

  Jia, W ^a   Shi, J G ^a   Wu, B ^a   Ao, L ^a   Zhang, R ^a   Zhu, Y S ^b  

^a SHANDONG MENTAL HEALTH CENTER   (China)

^b Key Laboratory of Reproduction and Genetics of Ningxia Hui Autonomous Region   (China)

Author keywords

Brain derived neurotrophic factor; Heroin dependence; Polymorphism

Indexed keywords

ADENINE; BRAIN DERIVED NEUROTROPHIC FACTOR; GUANINE;

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HEROIN DEPENDENCE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; BRAIN-DERIVED NEUROTROPHIC FACTOR; CHINA; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HEROIN DEPENDENCE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 79955576808     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2011.03.072     Document Type: Article

References (34)

1. Beuten J., Ma J.Z., Payne T.J., Dupont R.T., Quezada P., Huang W., Crews K.M., Li M.D. Significant association of BDNF haplotypes in European-American male smokers but not in European-American female or African-American smokers. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2005, 139B:73-80.
2. Bolanos C.A., Nestler E.J. Neurotrophic mechanisms in drug addiction. Neuromolecular Med. 2004, 5:69-83.
3. Borroni B., Grassi M., Archetti S., Costanzi C., Bianchi M., Caimi L., Caltagirone C., Di Luca M., Padovani A. BDNF genetic variations increase the risk of Alzheimer's disease-related depression. J. Alzheimers Dis. 2009, 18:867-875.
4. Cadoret R.J., Yates W.R., Troughton E., Woodworth G., Stewart M.A. Adoption study demonstrating two genetic pathways to drug abuse. Arch. Gen. Psychiatry 1995, 52:42-52.
5. Chen Z.Y., Jing D., Bath K.G., Ieraci A., Khan T., Siao C.J., Herrera D.G., Toth M., Yang C., McEwen B.S., Hempstead B.L., Lee F.S. Genetic variant BDNF (Val66Met) polymorphism alters anxiety-related behavior. Science 2006, 314:140-143.
6. Chen Z.Y., Patel P.D., Sant G., Meng C.X., Teng K.K., Hempstead B.L., Lee F.S. Variant brain-derived neurotrophic factor (BDNF) (Met66) alters the intracellular trafficking and activity-dependent secretion of wild-type BDNF in neurosecretory cells and cortical neurons. J. Neurosci. 2004, 24:4401-4411.
7. Cheng C.Y., Hong C.J., Yu Y.W., Chen T.J., Wu H.C., Tsai S.J. Brain-derived neurotrophic factor (Val66Met) genetic polymorphism is associated with substance abuse in males. Brain Res. Mol. Brain Res. 2005, 140:86-90.
8. de Cid R., Fonseca F., Gratacos M., Gutierrez F., Martin-Santos R., Estivill X., Torrens M. BDNF variability in opioid addicts and response to methadone treatment: preliminary findings. Genes Brain Behav. 2008, 7:515-522.
9. Egan M.F., Kojima M., Callicott J.H., Goldberg T.E., Kolachana B.S., Bertolino A., Zaitsev E., Gold B., Goldman D., Dean M., Lu B., Weinberger D.R. The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 2003, 112:257-269.
10. Gratacos M., Gonzalez J.R., Mercader J.M., de Cid R., Urretavizcaya M., Estivill X. Brain-derived neurotrophic factor Val66Met and psychiatric disorders: meta-analysis of case-control studies confirm association to substance-related disorders, eating disorders, and schizophrenia. Biol. Psychiatry 2007, 61:911-922.
11. Grimm J.W, Lu L., Hayashi T., Hope B.T., Su T.P., Shaham Y. Time-dependent increases in brain-derived neurotrophic factor protein levels within the mesolimbic dopamine system after withdrawal from cocaine: implications for incubation of cocaine craving. J. Neurosci. 2003, 23:742-747.
12. Grzywacz A., Samochowiec A., Ciechanowicz A., Samochowiec J. Family-based study of brain-derived neurotrophic factor (BDNF) gene polymorphism in alcohol dependence. Pharmacol. Rep. 2010, 62:938-941.
13. Guillin O., Diaz J., Carroll P., Griffon N., Schwartz J.C., Sokoloff P. BDNF controls dopamine D3 receptor expression and triggers behavioural sensitization. Nature 2001, 411:86-89.
14. Hariri A.R., Goldberg T.E., Mattay V.S., Kolachana B.S., Callicott J.H., Egan M.F., Weinberger D.R. Brain-derived neurotrophic factor val66met polymorphism affects human memory-related hippocampal activity and predicts memory performance. J. Neurosci. 2003, 23:6690-6694.
15. Hou H., Qing Z., Jia S., Zhang X., Hu S., Hu J. Influence of brain-derived neurotrophic factor (val66met) genetic polymorphism on the ages of onset for heroin abuse in males. Brain Res. 2010, 1353:245-248.
16. Itoh K., Hashimoto K., Shimizu E., Sekine Y., Ozaki N., Inada T., Harano M., Iwata N., Komiyama T., Yamada M., Sora I., Nakata K., Ujike H., Iyo M. Association study between brain-derived neurotrophic factor gene polymorphisms and methamphetamine abusers in Japan. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2005, 132B:70-73.
17. Kreek M.J., Nielsen D.A., Butelman E.R., LaForge K.S. Genetic influences on impulsivity, risk taking, stress responsivity and vulnerability to drug abuse and addiction. Nat. Neurosci. 2005, 8:1450-1457.
18. Lang U, Sander T., Lohoff F., Hellweg R., Bajbouj M., Winterer G., Gallinat J. Association of the met66 allele of brain-derived neurotrophic factor (BDNF) with smoking. Psychopharmacology (Berl.) 2007, 190:433-439.
19. Laviolette S.R., Gallegos R.A., Henriksen S.J., van der Kooy D. Opiate state controls bi-directional reward signaling via GABAA receptors in the ventral tegmental area. Nat. Neurosci. 2004, 7:160-169.
20. Li M.D., Burmeister M. New insights into the genetics of addiction. Nat. Rev. Genet. 2009, 10:225-231.
21. Lu L., Dempsey J., Liu S.Y., Bossert J.M., Shaham Y. A single infusion of brain-derived neurotrophic factor into the ventral tegmental area induces long-lasting potentiation of cocaine seeking after withdrawal. J. Neurosci. 2004, 24:1604-1611.
22. Matsushita S., Kimura M., Miyakawa T., Yoshino A., Murayama M., Masaki T., Higuchi S. Association study of brain-derived neurotrophic factor gene polymorphism and alcoholism. Alcohol Clin. Exp. Res. 2004, 28:1609-1612.
23. Montag C., Basten U., Stelzel C., Fiebach C., Reuter M. The BDNF Val66Met polymorphism and smoking. Neurosci. Lett. 2008, 442:30-33.
24. Mowla S.J., Farhadi H.F., Pareek S., Atwal J.K., Morris S.J., Seidah N.G., Murphy R.A. Biosynthesis and post-translational processing of the precursor to brain-derived neurotrophic factor. J. Biol. Chem. 2001, 276:12660-12666.
25. Nanko S., Kunugi H., Hirasawa H., Kato N., Nabika T., Kobayashi S. Brain-derived neurotrophic factor gene and schizophrenia: polymorphism screening and association analysis. Schizophr. Res. 2003, 62:281-283.
26. Numan S., Lane-Ladd S.B., Zhang L., Lundgren K.H., Russell D.S., Seroogy K.B., Nestler E.J. Differential regulation of neurotrophin and trk receptor mRNAs in catecholaminergic nuclei during chronic opiate treatment and withdrawal. J. Neurosci. 1998, 18:10700-10708.
27. Russo S.J., Mazei-Robison M.S., Ables J.L., Nestler E.J. Neurotrophic factors and structural plasticity in addiction. Neuropharmacology 2009, 56(Suppl. 1):73-82.
28. Sartor C.E., Agrawal A., Lynskey M.T., Bucholz K.K., Madden P.A., Heath A.C. Common genetic influences on the timing of first use for alcohol, cigarettes, and cannabis in young African-American women. Drug Alcohol Depend. 2009, 102:49-55.
29. Sofroniew M.V, Howe C.L., Mobley W.C. Nerve growth factor signaling, neuroprotection, and neural repair. Annu. Rev. Neurosci. 2001, 24:1217-1281.
30. Szekeres G., Juhasz A., Rimanoczy A., Keri S., Janka Z. The C270T polymorphism of the brain-derived neurotrophic factor gene is associated with schizophrenia. Schizophr. Res. 2003, 65:15-18.
31. Tang J., Xiao L., Shu C., Wang G., Liu Z., Wang X., Wang H., Bai X. Association of the brain-derived neurotrophic factor gene and bipolar disorder with early age of onset in mainland China. Neurosci. Lett. 2008, 433:98-102.
32. True W.R., Xian H., Scherrer J.F., Madden P.A., Bucholz K.K., Heath A.C., Eisen S.A., Lyons M.J., Goldberg J., Tsuang M. Common genetic vulnerability for nicotine and alcohol dependence in men. Arch. Gen. Psychiatry 1999, 56:655-661.
33. Zhang H., Ozbay F., Lappalainen J., Kranzler H.R., van Dyck C.H., Charney D.S., Price L.H., Southwick S., Yang B.Z., Rasmussen A., Gelernter J. Brain derived neurotrophic factor (BDNF) gene variants and Alzheimer's disease, affective disorders, posttraumatic stress disorder, schizophrenia, and substance dependence. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2006, 141B:387-393.
34. American Psychiatric Association Diagnostic and statistical manual of mental disorders 1994, American Psychiatric Press, Washington, DC. 4th Ed.